Respiratory Infections News

The FDA has set a deadline of January 2022 to decide on the full approval of the Pfizer-BioNTech COVID-19 vaccine, the companies said Friday.

Heart and inflammatory issues experienced by pediatric patients hospitalized with multisystem inflammatory syndrome in children mostly resolved within a few months, according to a study published in Pediatrics.

HIV is independently associated with a higher risk for severe or critical COVID-19, according to a WHO analysis of more than 15,000 people living with HIV globally.

Data now published in a major journal show that the Johnson & Johnson COVID-19 vaccine generated strong activity against SARS-CoV-2 for at least 8 months, including against variants of concern.

The monoclonal antibody cocktail of bamlanivimab plus etesevimab reduced the risk for COVID-19-related death and hospitalization among high-risk ambulatory patients compared with placebo, according to phase 3 trial results published today.

Three adults experienced severe flares related to systemic capillary leak syndrome immediately after receiving a COVID-19 vaccine, researchers wrote in Annals of Internal Medicine.

An intervention researchers hoped would improve infection management did not significantly reduce antimicrobial use among nursing home residents with dementia, data showed.

After weeks of declining case counts, followed by a plateau, the United States is seeing an increase in COVID-19 in many parts of the country again, a CDC official warned this week.

The FDA has said that Johnson & Johnson’s COVID-19 vaccine may lead to an increased risk for Guillain-Barré syndrome.

Multiple societies representing medical professionals recommended Tuesday that COVID-19 vaccination be required for all health care personnel “as a condition of employment.”